These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 24077667)

  • 1. Fecal calprotectin, MMP-9, and human beta-defensin-2 levels in pediatric inflammatory bowel disease.
    Kolho KL; Sipponen T; Valtonen E; Savilahti E
    Int J Colorectal Dis; 2014 Jan; 29(1):43-50. PubMed ID: 24077667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels.
    Hämäläinen A; Sipponen T; Kolho KL
    World J Gastroenterol; 2011 Dec; 17(47):5166-71. PubMed ID: 22215940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic value of a new fecal marker, matrix metalloprotease-9, in different types of inflammatory bowel diseases.
    Farkas K; Saródi Z; Bálint A; Földesi I; Tiszlavicz L; Szűcs M; Nyári T; Tajti J; Nagy F; Szepes Z; Bor R; Annaházi A; Róka R; Molnár T
    J Crohns Colitis; 2015 Mar; 9(3):231-7. PubMed ID: 25585596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fecal pyruvate kinase isoform M2 and calprotectin in assessment of pediatric inflammatory bowel disease severity and activity.
    Czub E; Nowak JK; Szaflarska-Poplawska A; Grzybowska-Chlebowczyk U; Landowski P; Moczko J; Adamczak D; Mankowski P; Banasiewicz T; Plawski A; Walkowiak J
    Acta Biochim Pol; 2014; 61(1):99-102. PubMed ID: 24649481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of fecal calprotectin with ESR, CRP and albumin discriminates more accurately children with Crohn's disease.
    Daniluk U; Daniluk J; Krasnodebska M; Lotowska JM; Sobaniec-Lotowska ME; Lebensztejn DM
    Adv Med Sci; 2019 Mar; 64(1):9-14. PubMed ID: 30237086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
    Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
    Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
    Ricciuto A; Fish J; Carman N; Walters TD; Church PC; Hansen BE; Crowley E; Siddiqui I; Nguyen GC; Kamath BM; Griffiths AM
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1098-1105.e1. PubMed ID: 29378308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Matrix Metalloprotease-9 and Lipocalin-2 as Biomarkers in Detecting Endoscopic Activity in Patients With Inflammatory Bowel Diseases.
    Buisson A; Vazeille E; Minet-Quinard R; Goutte M; Bouvier D; Goutorbe F; Pereira B; Barnich N; Bommelaer G
    J Clin Gastroenterol; 2018 Aug; 52(7):e53-e62. PubMed ID: 28723856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
    Yang Z; Clark N; Park KT
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal Human β-Defensin 2 in Children with Cystic Fibrosis: Is There a Diminished Intestinal Innate Immune Response?
    Ooi CY; Pang T; Leach ST; Katz T; Day AS; Jaffe A
    Dig Dis Sci; 2015 Oct; 60(10):2946-52. PubMed ID: 26271615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
    Mooiweer E; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of diagnostic performance between two quantitative rapid fecal calprotectin assays in detecting active inflammatory bowel disease.
    Lee JM; Jang JH; Ryu JH; Yoo J; Lee BI; Kim SJ; Oh EJ
    PLoS One; 2021; 16(8):e0255974. PubMed ID: 34383847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
    Mooiweer E; Severs M; Schipper ME; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    J Crohns Colitis; 2015 Jan; 9(1):50-5. PubMed ID: 25518048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Laboratory Markers in Addition to Symptoms for Diagnosis of Inflammatory Bowel Disease in Children: A Meta-analysis of Individual Patient Data.
    Holtman GA; Lisman-van Leeuwen Y; Day AS; Fagerberg UL; Henderson P; Leach ST; Perminow G; Mack D; van Rheenen PF; van de Vijver E; Wilson DC; Reitsma JB; Berger MY
    JAMA Pediatr; 2017 Oct; 171(10):984-991. PubMed ID: 28806445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Calprotectin, IL-6, and CRP in Distinguishing Between Inflammatory Bowel Disease and Diarrhea Predominant Irritable Bowel Syndrome.
    Huong BT; Hien NM; Dung NT; Quang DM; Vinh NT; Tu TT; Chi TK; Phuong LB; Nhan NT
    Med Arch; 2024; 78(2):105-111. PubMed ID: 38566874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.
    Sidler MA; Leach ST; Day AS
    Inflamm Bowel Dis; 2008 Mar; 14(3):359-66. PubMed ID: 18050298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin?
    Di Ruscio M; Vernia F; Ciccone A; Frieri G; Latella G
    Inflamm Bowel Dis; 2017 Dec; 24(1):78-92. PubMed ID: 29272479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease.
    Walkiewicz D; Werlin SL; Fish D; Scanlon M; Hanaway P; Kugathasan S
    Inflamm Bowel Dis; 2008 May; 14(5):669-73. PubMed ID: 18240279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.